跳至主要内容
临床试验/EUCTR2011-002987-26-DK
EUCTR2011-002987-26-DK进行中(未招募)不适用

Effects of high dose terbutaline on physical performance in patients with chronic obstructive pulmonary disease and acute inflammatory response after exercise - Effects of terbutaline on patients with COPD

Bispebjerg Hospital0 个研究点目标入组 10 人开始时间: 2011年8月10日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • -Sex: Male
  • -Age: 45-75
  • -COPD classified as GOLD2, with a FEV1 between 30 and 50%
  • -In a physical condition that allows cycling
  • -smoker or former smoker
  • -Informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Cardiovascular diseases
  • -Other respiratory diseases than COPD, as well as, lung cancer
  • -Allergy towards the study medicine
  • -Use of beta2-agonist 48 hours prior to study days
  • -COPD rehabilitation 3 months prior to study
  • -Patients treated with beta-blockers

研究者

相似试验